Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
investigational drug |
| gptkbp:CASNumber |
212779-48-1
|
| gptkbp:developedBy |
gptkb:Boehringer_Ingelheim
|
| gptkbp:hasMolecularFormula |
C22H16Cl2N2O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
doramapimod
|
| gptkbp:investigatedBy |
gptkb:Crohn's_disease
inflammatory diseases psoriasis rheumatoid arthritis |
| gptkbp:IUPACName |
4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)imidazole
|
| gptkbp:mechanismOfAction |
p38 MAP kinase inhibitor
|
| gptkbp:PubChem_CID |
CHEMBL121
10498042 DB06605 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:BIRB796
gptkb:BIRB_796 BIRB-796 |
| gptkbp:bfsParent |
gptkb:BIRB796
|
| gptkbp:bfsLayer |
7
|